Henshaw Capital LLC Has $1.42 Million Holdings in Envista Holdings Corporation $NVST

Henshaw Capital LLC decreased its position in shares of Envista Holdings Corporation (NYSE:NVSTFree Report) by 27.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 56,073 shares of the company’s stock after selling 21,009 shares during the quarter. Henshaw Capital LLC’s holdings in Envista were worth $1,423,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the company. Royal Bank of Canada raised its position in shares of Envista by 26.6% in the 1st quarter. Royal Bank of Canada now owns 23,240 shares of the company’s stock valued at $401,000 after buying an additional 4,885 shares in the last quarter. Millennium Management LLC increased its stake in Envista by 218.6% in the first quarter. Millennium Management LLC now owns 383,966 shares of the company’s stock valued at $6,627,000 after acquiring an additional 263,442 shares during the last quarter. Goldman Sachs Group Inc. raised its position in Envista by 39.3% during the first quarter. Goldman Sachs Group Inc. now owns 629,140 shares of the company’s stock valued at $10,859,000 after purchasing an additional 177,630 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in Envista by 15.5% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 568,982 shares of the company’s stock valued at $9,821,000 after purchasing an additional 76,246 shares in the last quarter. Finally, Prudential Financial Inc. lifted its stake in Envista by 22.1% during the second quarter. Prudential Financial Inc. now owns 18,785 shares of the company’s stock worth $367,000 after purchasing an additional 3,395 shares during the last quarter.

Envista Price Performance

Envista stock opened at $27.39 on Friday. The company has a current ratio of 2.44, a quick ratio of 2.06 and a debt-to-equity ratio of 0.47. The company has a market capitalization of $4.46 billion, a PE ratio of 66.80, a P/E/G ratio of 1.55 and a beta of 0.86. Envista Holdings Corporation has a 12 month low of $18.77 and a 12 month high of $30.42. The stock has a 50-day moving average price of $25.59 and a two-hundred day moving average price of $25.89.

Envista (NYSE:NVSTGet Free Report) last released its quarterly earnings results on Wednesday, May 6th. The company reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.31 by $0.05. Envista had a return on equity of 7.11% and a net margin of 2.41%.The company had revenue of $705.50 million for the quarter, compared to analysts’ expectations of $680.03 million. During the same period in the previous year, the business posted $0.24 earnings per share. The business’s quarterly revenue was up 14.4% compared to the same quarter last year. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Analysts expect that Envista Holdings Corporation will post 1.42 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on NVST shares. Robert W. Baird boosted their price target on Envista from $30.00 to $31.00 and gave the stock an “outperform” rating in a report on Thursday, May 7th. Piper Sandler lifted their target price on Envista from $25.00 to $26.00 and gave the company a “neutral” rating in a research report on Wednesday. Citigroup began coverage on shares of Envista in a report on Wednesday, April 15th. They issued a “neutral” rating and a $29.00 target price for the company. Zacks Research lowered shares of Envista from a “strong-buy” rating to a “hold” rating in a report on Monday, April 6th. Finally, Evercore reiterated an “outperform” rating and set a $33.00 price objective on shares of Envista in a research report on Thursday, May 7th. Six analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. Based on data from MarketBeat.com, Envista presently has an average rating of “Hold” and a consensus target price of $28.62.

Check Out Our Latest Analysis on Envista

Envista Company Profile

(Free Report)

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.

See Also

Institutional Ownership by Quarter for Envista (NYSE:NVST)

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.